This inventor holds 1 USPTO granted patent. Top assignee: 2Seventy Bio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Emily G. Kuiper and Her Patent in Cellular Immunotherapy.
Introduction
Emily G. Kuiper is an inventor associated with Arlington, Massachusetts, and 2seventy bio, Inc. Her listed patent concerns chimeric antigen receptor technology directed at BCMA, a target used in cellular immunotherapy research.
Latest Patents
Kuiper is credited with 1 patent: “BCMA Chimeric Antigen Receptors.” The patent relates to engineered receptors designed to recognize BCMA, a protein that can serve as a target in therapeutic approaches.
Career Highlights
Kuiper’s recorded patent work connects her to the development of BCMA-focused chimeric antigen receptor technology and to 2seventy bio, a biotechnology company working in cell therapies.
Collaborations
Kuiper is listed alongside coworker Shannon Grande Contrastano in connection with the provided information. Their shared association reflects collaborative work related to the BCMA chimeric antigen receptor patent.
Conclusion
Emily G. Kuiper’s patent record highlights her contribution to BCMA-targeted chimeric antigen receptor technology and her association with 2seventy bio, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile